Table 3

Clinical outcome according to VARC-2 criteria

eTAVI
n=23
eBAV
n=118
pElective TAVI after eBAV
n=32
p Value versus eTAVI
Bleeding17.4%
4/23
17.2%
20/116
0.9834.4%
11/32
0.16
 Life threatening4.3%
1/23
0.9%
1/116
0.203.1%
1/32
0.81
 Major4.3%
1/23
12.9%
15/116
0.2421.9%
7/32
0.07
 Minor8.7%
2/23
3.4%
4/116
0.569.4%
3/32
0.93
Vascular complications21.7%
5/23
12.9%
15/116
0.2715.6%
5/32
0.56
 Major17.4%
4/23
3.4%
4/116
0.01 12.5%
4/32
0.61
 Minor4.3%
1/23
9.5%
11/116
0.423.1%
1/32
0.81
Myocardial infarction0
023
4.4%
5/113
0.393.1%
1/32
0.39
Stroke8.7%
2/23
0
0/118
0.01 6.3%
2/32
0.73
Pacemaker implantation8.7%
2/23
7.8%
4/51
0.5112.9%
4/32
0.62
Acute kidney injury20.0%
3/15
30.6%
26/85
0.4133.3%
9/27
0.36
 Stage 121.7%
5/23
11.2%
10/89
0.0616.7%
5/30
0.07
 Stage 213.0%
3/23
2.2%
2/89
0
0/30
 Stage 30
0/23
15.7%
14/89
13.3%
4/30
Aortic regurgitation ≥II (up to III)4.3%
1/23
27.1%
19/70
0.02 12.9%
4/31
0.28
  • eBAV, emergency balloon valvuloplasty; eTAVI, emergency transcatheter aortic valve implantation; TAVI, transcatheter aortic valve implantation.